The Role of the Pharmacist in Optimizing Cancer Immunotherapy: A Retrospective Study of Nivolumab Adverse Events.
Bradley D MenzJacinta L JohnsonDavina F GillardWilliam ChongMichael B WardPublished in: Journal of pharmacy practice (2019)
The listed prevalence of adverse events and practice strategies identified throughout this study highlights how pharmacists may assist in the identification of predictable ICI toxicities associated with gastrointestinal, endocrine, dermatological toxicities, and fatigue.